Foundation Medicine, Inc.
FMI
FMI was delisted on the 30th of July, 2018.
92 hedge funds and large institutions have $203M invested in Foundation Medicine, Inc. in 2016 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 48 increasing their positions, 16 reducing their positions, and 10 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 16
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
2% more capital invested
Capital invested by funds: $200M → $203M (+$3.17M)
4% less funds holding
Funds holding: 96 → 92 (-4)
39% less call options, than puts
Call options by funds: $7.57M | Put options by funds: $12.5M
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Top Buyers
| 1 |
OC
Oppenheimer & Co
New York
|
+$4.54M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$2.58M |
| 3 |
Chevy Chase Trust
Bethesda,
Maryland
|
+$2.33M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$1.08M |
| 5 |
SM
Senvest Management
New York
|
+$1.07M |
Top Sellers
FMI Hedge Fund Activity: Q2 2016 in Review
92 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine, Inc. (FMI) for Q2 2016, worth a combined $203M — up 1.6% from $200M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of FMI and 6 opened new positions — a net loss of 4 holders — while 16 trimmed existing stakes and 48 added.
The largest buyer was Oppenheimer & Co, adding an estimated $4.54M. The largest seller was Wellington Management Group, exiting entirely with an estimated $13.6M sold.
- 92 institutional investors held Foundation Medicine, Inc. (FMI) as of Q2 2016, down from 96 in Q1 2016.
- Funds reported $203M of Foundation Medicine, Inc. stock for Q2 2016, up 1.6% quarter-over-quarter.
- 6 funds opened new Foundation Medicine, Inc. positions in Q2 2016 and 10 closed out, a net change of -4 holders.
- The largest Foundation Medicine, Inc. buyer in Q2 2016 was Oppenheimer & Co, an estimated $4.54M added.
- The largest Foundation Medicine, Inc. seller in Q2 2016 was Wellington Management Group, an estimated $13.6M sold.
Based on aggregated 13F filings for Q2 2016.